Heska Corporation
- Jurisdiction
United States - LEI
529900O1OR2EB7L0HY27 - ISIN
US42805E3062 (HSKA )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. Read full profile
Fundamentals
- Net revenue
€217.41M - Gross margin
42.9% - EBIT
-€14.61M - EBIT margin
-6.7% - Net income
-€15.86M - Net margin
-7.3%
Statement period: - (published )
Stock price
Dividends
- Last dividend amount
-
$0.10 - Ex date
-
- Payment date
-
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: February 28, 2023 (Q4 2022)